Ronald Hershow MD MPH
UIC School of Public Health/Rm 987
Dr. Hershow is engaged in epidemiologic research that mainly deals with human immunodeficiency virus in women, hepatitis C virus infection, and nosocomial infections. Specific areas of focus include investigation of viral coinfections and other cofactors that may influence HIV disease progression, the early natural history of hepatitis C virus infection, prevention of infectious disease morbidity in substance users, and the epidemiology of antibiotic-resistant microorganisms in hospitals. In summary, his research experience is extensive encompassing pathogenesis, epidemiologic, and prevention themes.
Dr. Hershow is a board-certified infectious disease clinician and has been at University of Illinois at Chicago School of Public Health since 1987. In recent years, he has studied risk factors associated with hepatitis C virus (HCV) and human T lymphotropic virus-type II (HTLV-II) infections in HIV-infected women. In addition, he has studied the effect of coinfecting viral infections (HCV and HTLV-II) on HIV disease progression and mother-to-child HIV transmission. Since 1987, he has served as principal investigator for three HIV natural history cohort studies involving gay men, injection drug users, and women with or at risk for HIV infection. Currently he is a site principal investigator for the multi-center NIH-funded Women Interagency HIV Study (WIHS), a natural history study of HIV infection in women. He also serves as chair of the Clinical Working Group and Drug Use Working Group for the NIH-funded Women and Infants Transmission Study (WITS), a multi-center study of HIV vertical transmission. In his role as chair of the Drug Use Working Group, he has developed an agenda to study the effect of HCV on HIV disease progression, the impact of HCV on liver disease in the maternal population of WITS, and has proposed to identify and study women who have recently acquired HCV infection during WITS follow-up. Lastly, Dr. Hershow has recently been funded by NIDA to assemble a mixed gender cohort of young injectors who have recently acquired HCV infection (a seroincident cohort) to study the early virology and natural history of HCV infection.
From 1987- 1999, Dr. Hershow served as the hospital epidemiologist at UIC hospital. Although he resigned from this position in 1999, he has maintained strong ties with the infection control department and has remained a member of the infection control committee. During his tenure in the infection control department he published articles on the epidemiology and virulence of methicillin-resistant Staphylococcus aureus and is currently investigating an outbreak of multi-antibiotic resistant Acinetobacter at the University of Illinois Hospital.
- Hershow RC, Galai N, Fukuda K, Graber J, Vlahov D, Rezza G, et al. An international collaborative study of the effects of coinfection with human T lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users. J Infect Dis. 174:309-317, 1996.
- Hershow RC, Riester KA, Lew J, et al. Increased vertical transmission of human immunodeficiency virus from hepatitis C coinfected mothers. J Infect Dis. 176:414-20, 1997.
- Hershow RC, Khayr WF, Schreckenberger PC. Ciprofloxacin resistance in methicillin-resistant staphylococcus aureus: Associated factors and resistance to other antibiotics. Am J Theraputics. 5:213-20, 1998.
- Hershow RC, Kalish LA, Sha B, Till M, Cohen M. Hepatitis C virus infection in Chicago women with or at risk of HIV infection: Evidence for sexual transmission. Sexually Transmitted Diseases. 25:527-532, 1998.
- Minkoff H, Hershow R, Watts DH, Frederick M, Cheng I, Tuomala R, Pitt J, Zorrilla CD, Hammill H, Adenyi-Jones SK, Thompson B. The relationship of pregnancy to human immunodeficiency disease progression. Am J Obstet Gynecol. 189:552-559, 2003.